Neuroscience

Brexanolone tolerated in super-refractory status epilepticus

(HealthDay)—For patients with super-refractory status epilepticus (SRSE), brexanolone as adjunctive therapy is tolerated and associated with a high rate of third-line agent (TLA) weaning, according to a study published ...

Obstetrics & gynaecology

Induction with concurrent oxytocin, foley speeds delivery

(HealthDay)—The rate of delivery within 24 hours is increased with induction with concurrent oxytocin infusion added to preinduction cervical ripening with a Foley catheter versus Foley followed by oxytocin, according to ...

Diseases, Conditions, Syndromes

Sleep disturbance linked to esophageal hypersensitivity

(HealthDay)—For patients with gastroesophageal reflux disease (GERD), sleep disturbance is associated with enhanced heartburn perception to capsaicin infusion, according to a study published online Nov. 29 in the Journal ...

Oncology & Cancer

A better pump for pediatric brain cancer

Treating pediatric brain cancer can be a challenge, since the brain has ways to protect itself from drugs taken orally or intravenously. One solution to this frustrating problem: A miniature, implantable infusion pump no ...

Psychology & Psychiatry

Anesthetic for depression? Study finds low-dose ketamine effective

Low-dose intravenous infusions of ketamine, a general anesthetic used in minor surgeries, given over a long period are an effective treatment for depression, Mayo Clinic researchers found. The study is published in the Journal ...

Surgery

In-transit melanoma advance is difficult to predict

(HealthDay)—Progressive disease cannot be reliably predicted by patient, clinical, or procedural factors in patients receiving regional therapy for advanced melanoma of the extremities, according to a study published online ...

page 7 from 10